Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Lancet (London, England)
|
September 9, 1989
Classical complement pathway in HIV infection
G Senaldi, M Peakman, T McManus, et al.
Journal of Clinical Pathology
|
October 1, 1987
Activation of the alternative complement pathway: clinical application of a new technique to measure fragment Ba
G Senaldi, M Peakman, A Alhaq, et al.
The Journal of Infectious Diseases
|
December 1, 1990
Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity
G Senaldi, M Peakman, T McManus, et al.
The New England Journal of Medicine
|
January 10, 1974
High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis
R M Galbraith, M Smith, R M Mackenzie, et al.
Lancet (London, England)
|
June 7, 1980
Plasma exchange in SLE
W A Hamilton, D Vergani, L Bevis, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1986
A toxicity study of recombinant interferon-gamma given by intravenous infusion to patients with advanced cancer
K Sriskandan, P Garner, J Watkinson, et al.
Lancet (London, England)
|
August 9, 1980
Joint symptoms, immune complexes, and rubella
D Vergani, P Morgan-Capner, E T Davies, et al.
British Journal of Cancer
|
October 1, 1986
The effect of adjuvant cyclophosphamide or tamoxifen on the numbers of lymphocytes bearing T cell or NK cell markers
C R Sheard, F Reilly, D E Tee, et al.
Lancet (London, England)
|
July 7, 1984
Pathogenesis of insulin-dependent diabetes: a role for activated T lymphocytes
L Alviggi, C Johnston, P J Hoskins, et al.
Clinical and Experimental Immunology
|
October 1, 1980
Identification of biliary antigens in circulating immune complexes in primary biliary cirrhosis
P Amoroso, D Vergani, B M Wojcicka, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Lancet (London, England)
|
September 9, 1989
Classical complement pathway in HIV infection
G Senaldi, M Peakman, T McManus, et al.
Journal of Clinical Pathology
|
October 1, 1987
Activation of the alternative complement pathway: clinical application of a new technique to measure fragment Ba
G Senaldi, M Peakman, A Alhaq, et al.
The Journal of Infectious Diseases
|
December 1, 1990
Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity
G Senaldi, M Peakman, T McManus, et al.
The New England Journal of Medicine
|
January 10, 1974
High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis
R M Galbraith, M Smith, R M Mackenzie, et al.
Lancet (London, England)
|
June 7, 1980
Plasma exchange in SLE
W A Hamilton, D Vergani, L Bevis, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1986
A toxicity study of recombinant interferon-gamma given by intravenous infusion to patients with advanced cancer
K Sriskandan, P Garner, J Watkinson, et al.
Lancet (London, England)
|
August 9, 1980
Joint symptoms, immune complexes, and rubella
D Vergani, P Morgan-Capner, E T Davies, et al.
British Journal of Cancer
|
October 1, 1986
The effect of adjuvant cyclophosphamide or tamoxifen on the numbers of lymphocytes bearing T cell or NK cell markers
C R Sheard, F Reilly, D E Tee, et al.
Lancet (London, England)
|
July 7, 1984
Pathogenesis of insulin-dependent diabetes: a role for activated T lymphocytes
L Alviggi, C Johnston, P J Hoskins, et al.
Clinical and Experimental Immunology
|
October 1, 1980
Identification of biliary antigens in circulating immune complexes in primary biliary cirrhosis
P Amoroso, D Vergani, B M Wojcicka, et al.
Page
of 5